| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Kirske David is a Chief Financial Officer at XFOR. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $446K at current prices.
Kirske David's largest disclosed position is in XFOR as Chief Financial Officer, worth about $446K. The recent filings there lean toward selling, a net 37,271 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | XFOR X4 Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 11,767 | $2.86 | $33,658.33 | -7.0% | - | - | |
| Jun 30, 2026 | XFOR X4 Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 8,543 | $4.26 | $36,428.21 | -4.8% | -35.4% | - | |
| May 12, 2026 | XFOR X4 Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 16,961 | $4.29 | $72,820.36 | -8.8% | -2.1% | - |